12th Annual ADMET Conference is organized by SMi Group and would be held during Jun 12 - 13, 2017 at Holiday Inn London - Kensington Forum, London, England, United Kingdom.
ADMET technologies determine properties of a drug candidate in the preclinical stage of drug discovery, and poor ADMET properties are a major cause for a candidate to fail in drug development. ADME-Toxicology has allowed pharmaceutical manufacturing companies to minimize drug discovery time, complications and to reduce costs. The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties is to increase the success rate of compounds reaching the development stage.